Accelerate translation for health and wealth

Model of the interaction between intasome and nucleosome structures.

Model of the interaction between intasome and nucleosome structures

 The Crick conducts discovery science, oriented towards solving human health challenges. Our translation and innovation strategy  focuses on maximising the value that can be generated from this science measured in terms of improvements in the lives of people in the UK and internationally, and in new economic opportunities.

We explore opportunities for new and improved therapies, diagnosis and prevention strategies. In many cases, this is accompanied by opportunities to form new businesses and grow existing ones; boost the supply of highly skilled and mobile people across the UK economy; and develop other activities that reinforce the UK's position at the forefront of global innovation in the life sciences.

The outstanding discovery science conducted at the Crick has the potential to drive important improvements in human health, both in the UK and globally.

To realise these health benefits, we have created an environment where basic and clinical scientists can work together closely and effectively.

The Crick does not have on-site facilities for patient-based research, but links with the clinical and regulatory expertise and networks available through the three university founders, their Academic Health Science Centres (AHSCs) and National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (BRCs).

This close working relationship fosters the development of experimental medicine, a key element of translational research.

  • Discovery with a purpose - to improve people's health and wellbeing - lies at the heart of the Francis Crick Institute.
  • Extensive links with clinical facilities and industry speed up the translation of discoveries made in the laboratory to effective treatments for disease.
  • Clinical and commercial translation are valued as highly as discovery research.